Related Experiment Video
Updated: Jul 3, 2026

11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Hyperimmunized patients awaiting cadaveric kidney graft: is there a quick desensitization possible?
1Department of Kidney Transplant Surgery, S. Orsola University Hospital, Bologna, Italy. alessandro.faenza@unibo.it
Transplantation Proceedings
|August 5, 2008
Summary
Highly immunized kidney transplant patients can benefit from rapid desensitization protocols. A quick plasmapheresis and IVIG treatment can turn positive crossmatch tests negative, improving transplant success rates.
Area of Science:
- Nephrology
- Immunology
- Transplantation
Background:
- Patients with high panel reactive antibody (PRA >80%) face significant challenges in kidney transplantation.
- Finding compatible donors with negative crossmatch tests (CMX) is difficult for highly sensitized individuals.
Purpose of the Study:
- To explore rapid desensitization protocols for kidney transplant candidates with high PRA.
- To evaluate the efficacy of plasmapheresis (PP) + low-dose intravenous immunoglobulin (IVIG) in converting positive CMX to negative.
Main Methods:
- Review of a case involving combined liver-kidney transplant where CMX converted post-liver operation.
- Proposal of a rapid desensitization protocol using PP + low-dose IVIG for selected high-PRA patients.
- Analysis of outcomes for patients with low-titer PRA undergoing this protocol.
Main Results:
- A combined liver-kidney transplant demonstrated CMX conversion within 8 hours, leading to a successful kidney transplant lasting over 3 years.
- The proposed rapid desensitization protocol offers a potential solution for patients with high, but not strong, immunization.
- This approach may convert positive CMX to negative, enabling transplantation with reduced immunosuppression risks.
Conclusions:
- Rapid desensitization protocols, such as PP + low-dose IVIG, show promise for improving transplant outcomes in highly sensitized kidney patients.
- This strategy allows for timely transplantation by converting positive CMX to negative, with immunosuppression initiated only when a kidney is available.
- Selected patients with high PRA may benefit from this accelerated approach, minimizing risks associated with prolonged desensitization.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Cell-mediated Immune Responses
Overview
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
